Home » Topics » Regulatory » Patents

Patents
RSS

Otsuka's new anti-H. pylori agents for GI disorders

Feb. 10, 1999

Cathepsin L inhibitor isolated by Yamanouchi

Feb. 10, 1999

New antibacterial series produced by Streptomyces discovered by Kyowa Hakko

Feb. 10, 1999

Fenamate-derived antiinflammatory agents in development at Abbott

Feb. 10, 1999

Oxazolidinones from P&U with broad-spectrum antibacterial activity

Feb. 9, 1999

Nonpeptide GnRH antagonists claimed by Merck & Co.

Feb. 9, 1999

Adjuvants and immunoeffectors from AGP series under evaluation at Ribi

Feb. 9, 1999

New photoactive agents in development at QLT and U. of British Columbia

Feb. 9, 1999

PKC inhibitors designed at Otsuka

Feb. 9, 1999

Antiallergic/antiasthmatic agents from Kaken acting specifically on eosinophils

Feb. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...